Search results
Here's Why We're Watching RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation
Simply Wall St. via Yahoo Finance· 9 hours agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
This RAPT Therapeutics Insider Increased Their Holding By 22% Last Year
Simply Wall St. via Yahoo Finance· 9 months agoViewing insider transactions for RAPT Therapeutics, Inc.'s (NASDAQ:RAPT ) over the last year, we see...
Rapt Therapeutics (RAPT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 1 year agoRapt Therapeutics (RAPT) possesses the right combination of the two key ingredients for a likely...
Can Rapt Therapeutics (RAPT) Climb 59% to Reach the Level Wall Street Analysts Expect?
Zacks via Yahoo Finance· 2 years agoThe average of price targets set by Wall Street analysts indicates a potential upside of 58.9% in...
Rapt Therapeutics (RAPT) Upgraded to Buy: Here's What You Should Know
Zacks via Yahoo Finance· 2 years agoRapt Therapeutics (RAPT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism...
Rapt Therapeutics (RAPT) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoRapt Therapeutics (RAPT) delivered earnings and revenue surprises of 17.33% and 121.50%,...
RAPT Therapeutics (NASDAQ:RAPT) adds US$74m to market cap in the past 7 days, though investors from...
Simply Wall St. via Yahoo Finance· 2 years agoRAPT Therapeutics, Inc. (NASDAQ:RAPT) shareholders should be happy to see the share price up 30% in...
Great news for RAPT Therapeutics, Inc. (NASDAQ:RAPT): Insiders acquired stock in large numbers last...
Simply Wall St. via Yahoo Finance· 1 year agoUsually, when one insider buys stock, it might not be a monumental event. But when multiple insiders...
Investors in RAPT Therapeutics (NASDAQ:RAPT) have unfortunately lost 44% over the last year
Simply Wall St. via Yahoo Finance· 1 year agoThe simplest way to benefit from a rising market is to buy an index fund. But if you buy individual...
RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Simply Wall St. via Yahoo Finance· 2 years agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...